Edition:
United Kingdom

Altimmune Inc (ALT.OQ)

ALT.OQ on NASDAQ Stock Exchange Global Market

2.46USD
17 Jun 2019
Change (% chg)

$-0.12 (-4.65%)
Prev Close
$2.58
Open
$2.58
Day's High
$2.58
Day's Low
$2.45
Volume
32,964
Avg. Vol
199,764
52-wk High
$36.25
52-wk Low
$1.70

About

Altimmune, Inc., formerly Pharmathene, Inc., is a clinical-stage immunotherapeutic company. The Company focuses in development of medical counter measures against biological and chemical threats. The Company is involved in development of two next generation anthrax vaccines. It has two proprietary platform technologies,... (more)
No analyst recommendations are available for .

Overall

Beta: 2.96
Market Cap(Mil.): $35.38
Shares Outstanding(Mil.): 15.59
Dividend: 29.10
Yield (%): --

Financials

  ALT.OQ Industry Sector
P/E (TTM): 0.08 69.30 32.55
EPS (TTM): 27.25 -- --
ROI: 326.16 8.90 13.82
ROE: 357.56 10.04 15.24

Earnings vs. Estimates